Itraconazole
![Itraconazole Structure](CAS/GIF/84625-61-6.gif)
- CAS No.
- 84625-61-6
- Chemical Name:
- Itraconazole
- Synonyms
- SPORANOX;Itrizole;ORICONAZOLE;traconazole;R51211;Orungal;Sempera;Sporamelt;Canditral;Itraconaz
- CBNumber:
- CB4716071
- Molecular Formula:
- C35H38Cl2N8O4
- Molecular Weight:
- 705.63
- MOL File:
- 84625-61-6.mol
- MSDS File:
- SDS
- Modify Date:
- 2024/4/23 13:02:50
Melting point | 166°C |
---|---|
Boiling point | 850.0±75.0 °C(Predicted) |
alpha | -0.1~+0.1°(D/20℃)(c=10,CH2Cl2) |
Density | 1.27 g/cm3 |
Flash point | >110°(230°F) |
storage temp. | 2-8°C |
solubility | chloroform: 50 mg/mL, clear, colorless |
pka | 3.7(at 25℃) |
form | White powder |
color | white |
Water Solubility | Insoluble in water. Solube in chloroform at 50 mg/ml. Slightly soluble in ethanol or methanol |
Merck | 14,5245 |
Stability | Stable. Incompatible with strong oxidizing agents. |
InChIKey | VHVPQPYKVGDNFY-UHFFFAOYSA-N |
CAS DataBase Reference | 84625-61-6(CAS DataBase Reference) |
SAFETY
Risk and Safety Statements
Symbol(GHS) | ![]() GHS07 |
|||||||||
---|---|---|---|---|---|---|---|---|---|---|
Signal word | Warning | |||||||||
Hazard statements | H302-H315-H319-H335 | |||||||||
Precautionary statements | P261-P264-P270-P301+P312-P302+P352-P305+P351+P338 | |||||||||
Hazard Codes | Xi,Xn,T,F | |||||||||
Risk Statements | 36/37/38-36/38-22-39/23/24/25-23/24/25-11 | |||||||||
Safety Statements | 22-26-36-45-36/37-16 | |||||||||
RIDADR | UN 3286 8(6.1)(3) / PGII | |||||||||
WGK Germany | 3 | |||||||||
RTECS | XZ5481000 | |||||||||
HS Code | 2934990002 | |||||||||
Toxicity | LD50 (14 day) in mice, rats, dogs (mg/kg): >320, >320, >200 orally (Van Cauteren) | |||||||||
NFPA 704 |
|
Itraconazole price More Price(6)
Manufacturer | Product number | Product description | CAS number | Packaging | Price | Updated | Buy |
---|---|---|---|---|---|---|---|
Sigma-Aldrich(India) | PHR1834 | Itraconazole Pharmaceutical Secondary Standard; Certified Reference Material | 84625-61-6 | 200MG | ₹18037.5 | 2022-06-14 | Buy |
Sigma-Aldrich(India) | I6657 | Itraconazole ≥98% (TLC) | 84625-61-6 | 100MG | ₹23111.38 | 2022-06-14 | Buy |
Sigma-Aldrich(India) | I-015 | Itraconazole solution 2.0?mg/mL (Methanol with 1% 1M HCl), ampule of 1?mL, certified reference material, Cerilliant? | 84625-61-6 | 1ML | ₹11251.8 | 2022-06-14 | Buy |
Sigma-Aldrich(India) | 419825 | Hh Signaling Antagonist X, Itraconazole - CAS 84625-61-6 - Calbiochem The Hh Signaling Antagonist X, Itraconazole, also referenced under CAS 84625-61-6, controls the biological activity of Hh pathway. This small molecule | 84625-61-6 | 250MG | ₹14100 | 2022-06-14 | Buy |
TCI Chemicals (India) | I0732 | Itraconazole | 84625-61-6 | 5G | ₹10900 | 2022-05-26 | Buy |
Itraconazole Chemical Properties,Uses,Production
Description
Itraconazole is an orally-active triazole antifungal indicated for use in the treatment of dermal, vaginal and systemic mycoses. In immunocompromised and AIDS patients, itraconazole has been shown to significantly reduce the incidence of relapses of cryptococcal meningitis.
Chemical Properties
Off-White Crystalline Solid
Uses
Itraconazole is a triazole antifungal agent. It is used to inhibit cytochrome P-450-dependent enzymes and ergosterol synthesis. It has been used against histoplasmosis, blastomycosis, cryptococcal meningitis, and aspergillosis. It?s different formulations are used to study Candida strains in murine invasive infections. It has been used to study proliferative changes of the forestomach mucosa in alloxan-induced diabetic rats..
Indications
Itraconazole (Sporanox) is effective in the treatment of histoplasmosis, blastomycosis,
candidiasis, and dermatophyte infection. Its efficacy in the treatment
of tinea capitis in children is equal to griseofulvin, and it is usually better
tolerated (21). It is metabolized by the cytochrome P-450 system and may
increase the levels ofwarfarin, cyclosporine, and digoxin among others. Its use
is contraindicated with certain medications.
Itraconazole (Sporanox) is a triazole antifungal that is related to the imidazole
ketoconazole. Similar to ketoconazole, it interferes with ergosterol
synthesis and cell membrane integrity. It is clinically active against dimorphic
fungi, yeast, dermatophytes, Blastomycetes, histoplasmosis, sporotrichosis,
and Aspergillus.
Itraconazole is a potent inhibitor of the cytochrome P450 3A enzyme
system, which may elevate blood levels of other drugs metabolized by this system
if taken concomitantly. Itraconazole levels may decrease in patients who
are concurrently taking rifampin, phenobarbital, or phenytoin. Cyclosporine,
felodipine, digoxin, warfarin, and oral hypoglycemic levels may increase when
given in conjunction with itraconazole.
Itraconazole, like ketoconazole, is contraindicated in patients taking cisapride.
Itraconazole may induce torsades de pointes, ventricular arrhythmias,
and congestive heart failure.
Antimicrobial activity
The spectrum includes dermatophytes, dimorphic fungi (Blast. dermatitidis, Coccidioides spp., Hist. capsulatum, Paracocc. brasiliensis, Penicillium marneffei and Spor. schenckii), molds (including Aspergillus spp.), dematiaceous fungi and yeasts (Candida spp. and Cryptococcus spp.).
Acquired resistance
This is uncommon, but fluconazole-resistant C. albicans and C. glabrata are often cross-resistant to itraconazole. There are reports of itraconazole-resistant strains of A. fumigatus.
General Description
Itraconazole is an antifungal drug prescribed for oral or intravenous treatment of fungal infections. The drug is sold under trade names such as Sporanoxor Onmel?. This Certified Spiking Solution? is suitable as starting material for calibrators, controls, or linearity standards for clinical and diagnostic testing or therapeutic drug monitoring of itraconazole in patient blood, serum, or plasma samples by LC-MS/MS or HPLC.
Pharmaceutical Applications
A synthetic dioxolane triazole available for oral or parenteral administration.
Clinical Use
Aspergillosis
Systemic mycoses with dimorphic fungi (blastomycosis,
coccidioidomycosis, histoplasmosis, paracoccidioidomycosis, penicilliosis)
Subcutaneous mycoses (chromoblastomycosis, sporotrichosis)
Mucosal and cutaneous candidosis.
Dermatophytosis
Phaeohyphomycosis
Pityriasis versicolor
Side effects
Unwanted effects are more common with oral solution than
with capsules, and are more severe. They include nausea,
abdominal discomfort, dyspepsia, diarrhea, headache, pruritus
and skin rash. Rare side effects include Stevens–Johnson
syndrome, transient abnormalities of liver enzymes, reversible
idiosyncratic hepatitis and hypokalemia.
Intravenous itraconazole has been associated with congestive
heart failure. Neither intravenous nor oral itraconazole should
be used to treat infections in patients with evidence of ventricular
dysfunction unless the expected benefit clearly exceeds
the risk. Patients with risk factors for congestive heart failure
should be treated with caution and their condition monitored.
Itraconazole Preparation Products And Raw materials
Raw materials
1of3
chevron_rightPreparation Products
Supplier | Tel | Country | ProdList | Advantage | Inquiry |
---|---|---|---|---|---|
Jigs Chemical ltd | +919099003427 | Gujarat, India | 239 | 58 | Inquiry |
HEMA PHARMACEUTICALS PVT LTD | +91-9537936912 +91-9537936912 | Gujarat, India | 48 | 58 | Inquiry |
SGMR PHARMACEUTICALS PVT LTD | +91-9032001889 +91-9032001889 | Telangana, India | 83 | 58 | Inquiry |
ANWITA APIS | +919000311012 | Hyderabad, India | 198 | 58 | Inquiry |
J S LABS | +91-7330612784 +91-7330612784 | Tamil Nadu, India | 160 | 58 | Inquiry |
TYNDAL LABS PVT LTD | +91-8008166674 +91-8008166674 | AndhraPradesh, India | 95 | 58 | Inquiry |
Shree HariKrishna Pharmaceuticals | +91-9925611910 +91-9925611910 | Gujarat, India | 16 | 58 | Inquiry |
Lee Pharma Ltd | +91-9849085929 +91-9849085929 | Hyderabad, India | 42 | 58 | Inquiry |
Virchow Groups | +919394860022 | Telangana, India | 24 | 58 | Inquiry |
Hetero Drugs Limited | +91-4023704923 +91-4023704923 | Telangana, India | 296 | 58 | Inquiry |
Supplier | Advantage |
---|---|
Jigs Chemical ltd | 58 |
HEMA PHARMACEUTICALS PVT LTD | 58 |
SGMR PHARMACEUTICALS PVT LTD | 58 |
ANWITA APIS | 58 |
J S LABS | 58 |
TYNDAL LABS PVT LTD | 58 |
Shree HariKrishna Pharmaceuticals | 58 |
Lee Pharma Ltd | 58 |
Virchow Groups | 58 |
Hetero Drugs Limited | 58 |
Related articles
- What is itraconazole used to treat?
- Itraconazole is a triazole antimycotic itraconazole used to treat systemic infections such as candidosis and aspergillosis inc....
- Mar 16,2024
- Itraconazole:Sporanoxs
- Itraconazole (Sporanoxs) is a synthetic triazole drug developed in the 1980s as the first orally bioavailable triazole agent. ....
- Mar 28,2022
84625-61-6(Itraconazole)Related Search:
1of4
chevron_right